Valeant Pharmaceuticals International Inc ( VRX.TO VRX.N ), responding to investors’ queries, said on Thursday that Executive Vice President Deb Jorn had not been asked to leave, reiterating that she had resigned for personal reasons. Jorn oversaw the Canadian drugmaker’s U.S.
